Breakthrough comments on Angelina Jolie's decision to have her ovaries and fallopian tubes removed to reduce her risk of developing cancer.
Angelina Jolie has announced that she's had preventative surgery to have her ovaries and fallopian tubes removed to reduce her risk of developing cancer. This follows her decision two years ago to have a preventative double mastectomy.
Chris Askew, Chief Executive of Breakthrough Breast Cancer, says:
“We praise Angelina for sharing her experience with the public – her commitment to raising awareness of BRCA gene faults and genetic testing is admirable. It’s so important for people to fully understand BRCA gene faults and what they could mean for women and their families.
“Faults in BRCA genes are rare, but can cause a significant increase in risk of breast and ovarian cancer. These inherited gene faults are responsible for around 5% of all breast cancer cases. Women with a strong family history of breast cancer may be eligible for genetic testing on the NHS and we advise anybody concerned about their own risk to talk to their GP.
“Finding out if there is a faulty BRCA gene allows women to make a decision about what they can do to reduce their risk of developing breast and ovarian cancer. This could mean a risk-reducing mastectomy and oophorectomy like Angelina, or for some it could be risk-reducing drugs, or extra screening to detect breast cancer early if it does occur. Breakthrough has developed family history guidelines which help women understand what family history means and tell them about the services available on the NHS."